Virginia Commonwealth University — Richmond, Virginia

Virginia Commonwealth University is a clinical research site located in Richmond, Virginia, United States 23298.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Virginia Commonwealth University has participated in 971 clinical trials with 246 currently active.

Therapeutic areas: Primary Malignant Brain Tumor, Glioblastoma (GBM), Astrocytoma.

Sponsors: Virginia Commonwealth University, Intercept Pharmaceuticals, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Commonwealth University?

Virginia Commonwealth University has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Commonwealth University conducted?

Virginia Commonwealth University has 971 clinical trials on record, with 246 currently active. Their work covers Primary Malignant Brain Tumor, Glioblastoma (GBM), Astrocytoma.

Is Virginia Commonwealth University accredited by Crixeo Health?

Virginia Commonwealth University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Virginia Commonwealth University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.